Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

DAFLON 500 mg COMPRIMIDOS RECUBIERTOS - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/DAFLON 500 mg COMPRIMIDOS RECUBIERTOS

Approved

STANDARD

DAFLON 500 mg COMPRIMIDOS RECUBIERTOS

Servier Austria Gmbh🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Jul 13, 2020
Approval ID: 4c496fb5a4fd6518
Company: Servier Austria Gmbh
Type: Standard

Approval Details

Approval Id: 4c496fb5a4fd6518
Drug Cima Aemps Name: DAFLON 500 mg COMPRIMIDOS RECUBIERTOS
Register Number: 1-20685IP
Holder Company Name: Servier Austria Gmbh
Marketing Company Name: Ecofar Productos S.L.
Authorization Date: 2020-07-13
Dosage Form: COMPRIMIDO RECUBIERTO
Dose: 500 mg
Route Of Administration: VÍA ORAL
Prescription Type: Sin Receta
Commercialized: Yes
Company Name: Servier Austria Gmbh

Active Ingredients

DIOSMINA

450 mg

HESPERIDINA

50 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Jul 13, 2020

Approval ID

4c496fb5a4fd6518

Type

Standard

Back to CIMA-AEMPS Approvals